5Counter CM,Gupta J,Harleoy CB,et al.Telomerase activity in normal leukoeytes and in hematologic malignanies.Blood,1995,85(10):2315-2310.
6Yoshida K,Sakamoto S,Sumi,et al.Telomerase activity in renal cell carcimoma.Cancer,1998,83(4):760-766.
7Yhata N,ohyashiki JH,et al.Telomerase activity in lung cancer cells obtained washings[J].J Natl Caner Inst,1998,90(9):684-690.
8Ohmura Y,Aoe M,Andou A,et al.Telomerase activity and Bd-2 expression in non-small cell lung caner Clin Caner RES,200,6(8):2080-2987.
9Tatsurmoto N,Hiyama I,Murakami Y,et al.High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer,Clin Cancer Res,2000,6(7):2696-2701.
10Kim NW,Piatyszek MA,Prowse,et al.Specific association of human telomerase activity with immortal cells and cancer.Science,1994,266(23):2011-2015.
二级参考文献32
1[1]Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science,1994,266(5193)∶2011-2016.
2[2]Kim NW, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res,1997,25(13)∶2595-2602.
3[3]Hiyama K, Hiyama E, Ishioka S, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst,1995,87(12)∶895-902.
4[4]Tatsumoto N, Hiyama E, Murakami Y, et al. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin Cancer Res,2000,6(7)∶2696-2701.
5[5]Blasco MA, Lee HW, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell,1997,91(1)∶25-31.
6[6]Sen S, Reddy VG, Khanna N, et al. A comparative study of telomerase activity in sputum, bronchial washing and biopsy specimens of lung cancer. Lung Cancer,2001,33(1)∶41-49.
7[7]Yahata N, Ohyashiki K, Ohyashiki JH, et al. Telomerase activity in lung cancer cells obtained from bronchial washings. J Natl Cancer Inst,1998,90(9)∶684-690.
8[8]Ohmura Y, Aoe M, Andou A, et al. Telomerase activity and Bcl-2 expression in non-small cell lung cancer. Clin Cancer Res,2000,6(8)∶2980-2987.
9[9]Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science,1995,269(5228)∶1236-1241.
10[10]Kondo S, Tanaka Y, Kondo Y, et al. Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J,1998,12(10)∶801-811.
